Our Firm

Our Firm

Green Griffith is a preeminent intellectual property law firm, uniquely qualified to assist small and mid-sized pharmaceutical and biotech companies protect their most valuable assets and position them for future success.
Learn More >
Our Team

Our Team

Our technical knowledge makes the difference: all of our attorneys have degrees in pharma-related fields, including organic chemistry, chemical engineering and molecular biology, and many have advanced degrees.
Learn More >
Our Clients

Our Clients

Our clients are both generics and brand, small and mid-sized pharmaceutical and biotech companies, focused on securing market position and/or overcoming obstacles to new product entry for their drugs and therapies.​​
Learn More >

News and Insights

District Court Finds Safe Harbor Defense Does Not Apply to Continued Process Verification Program Undertaken by Biosimilar Applicant

The Biologics Price Competition and Innovation Act of 2009 (“BPCIA”) creates an artificial act of infringement similar to that of 3…
Read More >

U.S. News Ranks Green Griffith as One of Nation’s Best

Green Griffith has received the following rankings in the 2019 edition of U.S. News – Best Lawyers® “Best Law Firms”: &…
Read More >

Burden to Rebut Obviousness in IPR Proceedings May Properly Be Placed on Patentee in the Context of Overlapping Prior Art Numerical Ranges

Under Federal Circuit precedent, a presumption of obviousness typically exists when numerical ranges recited in a claim overlap with ranges discl…
Read More >

Federal Circuit Confirms Standing to Appeal IPR Decision in Absence of Infringement Lawsuit

In a September 17, 2018, decision (E.I. DuPont de Nemours v. Synvina, Appeal No. 2017-1977, available here), the Federal Circuit confirmed that D…
Read More >